Related Experiment Video
Updated: Jan 22, 2026

Substrate Generation for Endonucleases of CRISPR/Cas Systems
Published on: September 8, 2012
Target preference of Type III-A CRISPR-Cas complexes at the transcription bubble
Tina Y Liu1,2, Jun-Jie Liu1,2,3, Abhishek J Aditham4
1Department of Molecular and Cell Biology, University of California, Berkeley, CA, 94720, USA.
Abstract:
Type III-A CRISPR-Cas systems are prokaryotic RNA-guided adaptive immune systems that use a protein-RNA complex, Csm, for transcription-dependent immunity against foreign DNA. Csm can cleave RNA and single-stranded DNA (ssDNA), but whether it targets one or both nucleic acids during transcription elongation is unknown. Here, we show that binding of a Thermus thermophilus (T. thermophilus) Csm (TthCsm) to a nascent transcript in a transcription elongation complex (TEC) promotes tethering but not direct contact of TthCsm with RNA polymerase (RNAP). Biochemical experiments show that both TthCsm and Staphylococcus epidermidis (S. epidermidis) Csm (SepCsm) cleave RNA transcripts, but not ssDNA, at the transcription bubble. Taken together, these results suggest that Type III systems primarily target transcripts, instead of unwound ssDNA in TECs, for immunity against double-stranded DNA (dsDNA) phages and plasmids. This reveals similarities between Csm and eukaryotic RNA interference, which also uses RNA-guided RNA targeting to silence actively transcribed genes.
Insights
Type III-A CRISPR-Cas systems use Csm complexes for bacterial immunity. This study shows Csm targets RNA transcripts during transcription, not DNA, revealing similarities with eukaryotic RNA interference.
Area of Science:
- Microbiology
- Molecular Biology
- Immunology
Background:
- Type III-A CRISPR-Cas systems provide prokaryotic adaptive immunity against foreign DNA using Csm complexes.
- Csm complexes are known to cleave both RNA and single-stranded DNA (ssDNA).
- The specific target of Csm during transcription elongation remained unclear.
Purpose of the Study:
- To determine whether Type III-A CRISPR-Cas Csm complexes target RNA or ssDNA during transcription elongation.
- To investigate the interaction between Csm and the transcription elongation complex (TEC).
Main Methods:
- Biochemical experiments were conducted using Thermus thermophilus Csm (TthCsm) and Staphylococcus epidermidis Csm (SepCsm).
- The study analyzed the binding and cleavage activities of Csm within transcription elongation complexes (TECs).
Main Results:
- TthCsm binding to nascent transcripts in TECs promotes tethering to RNA polymerase (RNAP) without direct contact.
- Both TthCsm and SepCsm were shown to cleave RNA transcripts within the transcription bubble.
- Neither Csm complex demonstrated cleavage activity against ssDNA in the transcription bubble.
Conclusions:
- Type III-A CRISPR-Cas systems primarily target RNA transcripts for immunity against foreign DNA, rather than unwound ssDNA in TECs.
- This RNA-targeting mechanism in prokaryotes shares similarities with eukaryotic RNA interference pathways.
- The findings clarify the molecular mechanism of transcription-dependent immunity mediated by Csm complexes.
Related Concept Videos
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR
Transcription
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
Transcription Factors
Electron Transport Chain: Complex III and IV
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...

